Tag: CPAP Alternative
Apnimed shares positive results for sleep apnea pill
May 19, 2025HME News Staff
CAMBRIDGE, Mass. - Apnimed has announced positive topline results from its pivotal Phase 3 SynAIRgy clinical trial evaluating the efficacy and safety of AD109 in adults living with mid, moderate and severe OSA and across all weight classes. The SynAIRgy trial met its primary endpoint: mean change from baseline in the apnea-hypopnea index (AHI) at 26 weeks compared to placebo (p=0.001). “Today is a landmark moment for Apnimed and for millions living with OSA who have long struggled with limited...
apZme secures more VA business for CPAP alternative
April 29, 2025HME News Staff
HOLLYWOOD, Fla. – Dental sleep medicine company apZme has announced that additional clinics have been credentialed through the U.S. Department of Veterans Affairs, bringing its total number of clinics to nearly 100 across the United States. Each clinic is approved to provide oral appliance therapy to veterans seeking alternatives to CPAP therapy. "It's an honor to serve the ones who served," said Rani Ben-David, chairman and founder of apZme. "This expansion shows our...
Health-E Commerce offers CPAP alternative
April 8, 2025HME News Staff
DALLAS – Health-E Commerce has launched a new telehealth collaboration with Daybreak to make sleep apnea testing and treatment available at the FSA Store and HSA Store. Participants will receive a convenient at-home sleep test that is analyzed by the Daybreak’s team of board-certified physicians. If treatment is needed, the company will send an at-home impression kit and corresponding shipping materials. Once the completed impression kit is returned, it takes two to three weeks for a...
Signifier meets CMS requirements for reimbursement
March 10, 2025HME News Staff
LONDON – Signifier Medical Technologies Limited has introduced its newest SKU, 18010, which features a hardware remote control specifically designed to meet CMS requirements for reimbursement. The company says the development ensures that its eXciteOSA therapy can be more readily accessible for Medicare and Medicaid beneficiaries. “eXciteOSA is a life-changing device helping patients address a root cause of sleep apnea and other sleep disorders,” said Mujtaba Chohan, head of finance...
Signifier’s CPAP alternative approved by Georgia Medicaid
February 17, 2025HME News Staff
LONDON – Signifier Medical Technologies has announced that its eXciteOSA non-invasive therapy for obstructive sleep apnea is now covered under Georgia Medicaid policy 1320, expanding access to more than 1.5 million people who live in the state. “This decision underscores the critical importance of providing accessible, effective solutions for Georgians living with obstructive sleep apnea,” said Akhil Tripathi, director and founder of Signifier. “By including eXciteOSA in Medicaid...
Rotech excited about CPAP alternative
December 20, 2024HME News Staff
ORLANDO, Fla. – Rotech Healthcare recently partnered with Signifier Medical Technologies to offer the eXciteOSA device as an alternative option for OSA, part of the provider’s commitment to serving all patients, says CEO Robin Menchen.
The eXciteOSA device allows daytime treatment for approximately 20 minutes twice a day for the initial treatment period, which is ideal for those patients who cannot tolerate CPAP treatment when trying to sleep, she said.
“Our...
Rotech to supply CPAP alternative
November 26, 2024HME News Staff
ORLANDO, Fla. – Rotech Healthcare has announced a supplier agreement with Signifier Medical Technologies to introduce the eXciteOSA device to payers, health care providers and patients to treat mild to moderate obstructive sleep apnea.
The eXciteOSA device, approved by the U.S. Food and Drug Administration, uses neuromuscular electrical stimulation to tone tongue muscles to maintain an open airway during sleep, improving sleep quality and overall health.
“Partnering...
Inspire Medical Systems gets green light for V
August 5, 2024HME News Staff
MINNEAPOLIS – Inspire Medical Systems has announced approval from the U.S. Food and Drug Administration for the Inspire V therapy system, which includes a next generation neurostimulator for the treatment of obstructive sleep apnea. The system also includes the associated Bluetooth patient remote and physician programmer. “We are thrilled to announce the FDA approval of our next generation Inspire neurostimulation system,” said Tim Herbert, chairman and CEO of Inspire Medical Systems....
Signifier’s CPAP alternative greenlighted by SC Medicaid
April 8, 2024HME News Staff
BOSTON – Signifier Medical Technologies has announced that its eXciteOSA therapy for sleep-disordered breathing is now covered by South Carolina’s Health Connections Medicaid program. This coverage opens new doors for patients 18 and older who have previously had limited access to advanced treatments for obstructive sleep apnea. "We are thrilled that eXciteOSA is now covered by Medicaid in South Carolina," states Akhil Tripathi, director and co-founder of Signifier. "This...
ProSomnus raises $10M
September 25, 2023HME News Staff
PLEASANTON, Calif. – ProSomnus, which makes a CPAP alternative for the treatment of obstructive sleep apnea, has completed a $10 million convertible preferred equity offering led by existing investors Spring Mountain Capital and Cetus Capital. The company will use the new capital to optimize its core business operations and support its strategic growth initiatives as it strives to achieve cash flow breakeven. “The completion of this financing fortifies our balance sheet as we continue...